What Happened?
Waltham, MA-based Arrakis-Therapeutics Appointed Michael Gilman as Chairman and Chief Executive Officer
About the Company
Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA. Arrakis is building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines focused on cancer and genetically validated targets in other disease areas. The company brings together scientific leaders in RNA structure, chemistry and biology, along with a highly experienced management team and the backing of leading life sciences investors. The company is located in Waltham, Massachusetts.
About the Person
Michael Gilman is Chief Executive Officer and Chairman at Obsidian Therapeutics. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile